Moore Capital Management LP bought a new stake in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) in the 2nd quarter, Holdings Channel.com reports. The firm bought 61,481 shares of the company’s stock, valued at approximately $1,569,000.
Other institutional investors have also added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd boosted its stake in shares of Azenta by 2,067.6% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 802 shares of the company’s stock worth $27,000 after acquiring an additional 765 shares during the last quarter. Osaic Holdings Inc. increased its stake in shares of Azenta by 44.9% in the 2nd quarter. Osaic Holdings Inc. now owns 1,242 shares of the company’s stock worth $39,000 after purchasing an additional 385 shares in the last quarter. Rockefeller Capital Management L.P. raised its holdings in Azenta by 98.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 1,392 shares of the company’s stock worth $46,000 after purchasing an additional 689 shares during the period. Van ECK Associates Corp raised its holdings in Azenta by 141.2% in the 4th quarter. Van ECK Associates Corp now owns 1,585 shares of the company’s stock worth $53,000 after purchasing an additional 928 shares during the period. Finally, State of Wyoming purchased a new position in Azenta during the first quarter valued at $38,000. 99.08% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several research firms have issued reports on AZTA. Needham & Company LLC boosted their price target on Azenta from $33.00 to $37.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. Four research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $41.20.
Azenta Stock Down 0.9%
Shares of Azenta stock opened at $32.65 on Tuesday. The company has a market capitalization of $1.43 billion, a price-to-earnings ratio of -11.83 and a beta of 1.36. The stock’s 50-day simple moving average is $29.14 and its 200-day simple moving average is $25.18. Azenta, Inc. has a 52 week low of $15.93 and a 52 week high of $41.73.
Azenta (NASDAQ:AZTA – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. The firm had revenue of $161.18 million during the quarter, compared to analysts’ expectations of $149.31 million. Azenta had a positive return on equity of 1.18% and a negative net margin of 20.63%.
Azenta Company Profile
Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.
In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.
Recommended Stories
- Five stocks we like better than Azenta
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.
